4.2 Review

Alzheimer's beta-secretase cleaves a glycosyltransferase as a physiological substrate

期刊

GLYCOCONJUGATE JOURNAL
卷 20, 期 1, 页码 59-62

出版社

SPRINGER
DOI: 10.1023/B:GLYC.0000016743.25495.45

关键词

Alzheimer's disease; amyloid precursor protein; amyloid beta-peptide; beta-secretase; alpha 2,6-sialyltransferase; glycosyltransferases; proteolytic cleavage; alpha 2,6-sialylation; Golgi apparatus; secretion; CD22/Siglec-2 signaling

向作者/读者索取更多资源

Alzheimer's beta-secretase (BACE1) is a membrane-bound protease that cleaves the amyloid precursor protein (APP) in the trans-Golgi network, an initial step in the pathogenesis of Alzheimer's disease. Although BACE1 is distributed among various tissues including brain, its physiological substrate other than APP have not been identified. We have recently found that when BACE1 was overexpressed in COS cells together with alpha2,6-sialyltransferase (ST6Gal I), the secretion of ST6Gal I markedly increased, suggesting that BACE1 cleaves ST6Gal I as a physiological substrate. Thus BACE1 is the first identified protease that is responsible for the cleavage and secretion of glycosyltransferases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据